StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Verbindung

Succinate

HCID 160419
Neue NotizNeue ReaktionAnfrage stellen
Druckvorschau

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
56-14-4
Standard-SMILES
O=C([O-])CCC(=O)[O-]
InChIKey
KDYFGRWQOYBRFD-UHFFFAOYSA-L
Summenformel
C4H4O4-2
Durchschnittliche Molmasse
116,07 g/mol
Monoisotopische Masse
116,01205577

Überblick

Succinate(2-) is a dicarboxylic acid dianion resulting from the removal of a proton from both of the carboxy groups of succinic acid. It has a role as a Saccharomyces cerevisiae metabolite and a human metabolite. It is a succinate, a dicarboxylic acid dianion and a C4-dicarboxylate. It is a conjugate base of a succinate(1-).

Namen und Bezeichner

Bevorzugter Name
Succinate
IUPAC
butanedioate
Englischer Name
ANION STANDARD - SUCCINATE
Summenformel
C4H4O4-2
Molmasse
116.07216

Namen und Synonyme

succinateButanedioateSuccinate dianion56-14-4AJ326AG789DTXSID4036772RefChem:932339DTXCID2016772CHEBI:26806Butanedioic acid, ion(2-)Succinate ionSuccinic acid, ion(2-)
Weitere Namen anzeigen
ANION STANDARD - SUCCINATEOrganic Acid Salt Standard - Succinate@1000 μg/mL in Water
succmonosuccinatesuccinate(2-)Butanedioate(2-)UNII-AJ326AG789Succinate ion(2-)sucCHEBI:30031

Datenbank-Bezeichner

CAS
56-14-4
PubChem CID
160419
DTXSID
DTXSID4036772
ChEBI
CHEBI:30031
UNII
AJ326AG789
EC Number
611-361-4
Nikkaji
J215.983J

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
0,7
Polarare Oberfläche (TPSA)
80,3 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
1
Schwere Atome
8
Formalladung
-2
Komplexität
81,6

Experimentelle und physikochemische Eigenschaften

Collision Cross Section115.9 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Toxikologische Informationen

Treatment · 1 Eintrag

EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration.

Health Effects · 1 Eintrag

At acute doses or exposures succinic acid is a skin irritant. Chronically high doses of succinate can lead to succinylation or succination of a variety of enzymes. Partial succinate dehydrogenase deficiency (15% to 50% of normal reference enzyme activity) in skeletal muscle leads to elevated succinate levels and causes mitochondrial myopathy with various symptoms, for example, brain involvement, cardiomyopathy, and/or exercise intolerance.

Exposure RoutesEye contact, Inhalation, Ingestion.
Toxicity Summary · 1 Eintrag

Succinate can inhibit the activities of α-KG–dependent oxygenases (KDMs) and the TET family of 5-methlycytosine (5mC) hydroxylases. Succinate also mediates allosteric inhibition of hypoxia inducible factor (HIF) prolyl hydroxylases (PHDs). Inhibition of HIF PHDs leads to activation of HIF-mediated pseudohypoxic response, whereas inhibition of KDMs and TET family of 5mC hydroxylases causes epigenetic alterations that ultimately cause cancer. Succination of KEAP1 in FH deficiency results in the constitutive activation of the antioxidant defense pathway mediated by NRF2, conferring a reductive milieu that promotes cell proliferation. Succination of the Krebs cycle enzyme Aco2 impairs aconitase activity in Fh1-deficient MEFs. Succination also causes irreversible inactivation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).

Signs and Symptoms

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesSuccinic acid can be converted into fumaric acid by oxidation via succinate dehydrogenase.

Verwendung und Herstellung

Uses · 1 Eintrag

Succinic acid is a precursor to some specialized polyesters. It is also a component of some alkyd resins. Succinic acid is used in the food and beverage industry, primarily as an acidity regulator. It is also sold as a food additive and dietary supplement, and is generally recognized as safe by the US FDA.

Ergänzende Hinweise

DefinitionChEBI: A dicarboxylic acid dianion resulting from the removal of a proton from both of the carboxy groups of succinic acid.

Zugehörige Reaktionen

51
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 95584
HRID 95584als EduktTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
Reaktionsgleichung von HRID 272524
HRID 272524als Eduktuspto-grants-2008_11
Reaktionsgleichung von HRID 272525
HRID 272525als Eduktuspto-grants-2008_11
Reaktionsgleichung von HRID 273287
HRID 273287als Eduktuspto-grants-2008_11
Reaktionsgleichung von HRID 305845
HRID 305845als EduktTraining data from https://doi.org/10.1039/C8SC04228D (8/10)
Reaktionsgleichung von HRID 382220
HRID 382220als Eduktuspto-grants-2001_10
Reaktionsgleichung von HRID 428476
HRID 428476als Eduktuspto-grants-2001_11
Reaktionsgleichung von HRID 429696
HRID 429696als Eduktuspto-grants-2001_11
Seite 1 von 7

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Weitere Aktionen
Neue NotizNeue ReaktionAnfrage stellen
Acute Exposure: the clinical signs of acute toxicity are weakness and diarrhea.
Carcinogen ClassificationNot listed by IARC. Has been implicated in oncogenesis (A15088).
Toxicity DataAcute oral toxicity (LD50): 2260 mg/kg [Rat].